© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
March 31, 2021
Investigators offer a review of the most recent literature depicting the relationship between estrogen and the incidence of migraine headache.
If approved, atogepant will be the first oral CGRP receptor specifically developed for the preventive treatment of migraine.
March 19, 2021
A recent analysis evaluated the role of dietary magnesium consumption for migraine.
March 12, 2021
Research presented during the APhA 2021 Annual Meeting and Exposition examined the clinical use of ketamine as an abortive therapy for migraines and primary headaches.
March 09, 2021
The study findings will be presented at the American Academy of Neurology’s 73rd Annual Meeting.
March 08, 2021
Migraine is frequently comorbid with asthma. A new analysis examines whether there is a direct relationship between the 2 diseases.
February 24, 2021
In a systematic review, investigators aim to understand the mechanisms for comorbid bipolar disorder and migraine, as well as therapeutic targets.
February 17, 2021
In addition to reducing the frequency of migraine days, galcanezumab may also potentially decrease disabling non-pain symptoms of migraine on days when migraine is present.
February 10, 2021
The relatively new biologic therapies for migraine demonstrated low immunogenicity rates and rare adverse events.
February 09, 2021
Pharmacists are well positioned to support the care of patients with migraines and offer advice on treatments.